Dietary nutrition and gut microflora: A promising target for treating diseases

Trends in Food Science and Technology

Volumn 75, Issue , 2018, Pages 72-80

  Nie, Ying ^a,b   Luo, Feijun ^a   Lin, Qinlu ^a  

^a CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

^b Hunan Biological and Electromechanical Polytechnic   (China)

Author keywords

Diet; Functional foods; Gut microflora; Nutrients; Therapeutic treatment

Indexed keywords

FUNCTIONAL FOOD; METABOLISM; MICROORGANISMS; NUTRIENTS;

DIETARY COMPONENTS; ENERGY METABOLISM; GASTROINTESTINAL TRACT; GUT MICROBIOTA; GUT MICROFLORA; MENTAL DISEASE; MICROBIAL COMPOSITION; THERAPEUTIC TREATMENTS;

NUTRITION;

EID: 85045724170     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2018.03.002     Document Type: Review

References (100)

1. Alcock, J., Maley, C.C., Aktipis, C.A., Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays 36 (2014), 940–949.
2. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 15718–15723.
3. Barrett, J.S., Gearry, R.B., Muir, J.G., Irving, P.M., Rose, R., Rosella, O., et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Alimentary Pharmacology & Therapeutics 31 (2010), 874–882.
4. Belizario, J.E., Napolitano, M., Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Frontiers in Microbiology 6 (2015), 1050–1055.
5. Bene, K., Varga, Z., Petrov, V.O., Boyko, N., Rajnavolgyi, E., Gut microbiota species can provoke both inflammatory and tolerogenic immune responses in human dendritic cells mediated by retinoic acid receptor alpha ligation. Frontiers in Immunology, 8, 2017 427–423.
6. Ben, X.M., Li, J., Feng, Z.T., Shi, S.Y., Lu, Y.D., Chen, R., et al. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World Journal of Gastroenterology 14 (2008), 6564–6568.
7. Benno, Y., Endo, K., Miyoshi, H., Okuda, T., Koishi, H., Mitsuoka, T., Effect of rice fiber on human fecal microflora. Microbiology and Immunology 33 (1989), 435–440.
8. Bergman, E.N., Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiological Reviews 70 (1990), 567–590.
9. Blanton, L.V., Charbonneau, M.R., Salih, T., Barratt, M.J., Venkatesh, S., Ilkaveya, O., et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 351 (2016), 830–847.
10. Blaser, M.J., Falkow, S., What are the consequences of the disappearing human microbiota?. Nature Reviews Microbiology 7 (2009), 887–894.
11. Bolnick, D.I., Snowberg, L.K., Hirsch, P.E., Lauber, C.L., Org, E., Parks, B., et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nature Communications 5 (2014), 4500–4512.
12. Bull-Otterson, L., Feng, W., Kirpich, I., Wang, Y., Qin, X., Liu, Y., et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One, 8, 2013, e53028.
13. Candon, S., Perez-Arroyo, A., Marquet, C., Valette, F., Foray, A.P., Pelletier, B., et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS One 10 (2015), e0125448–e125463.
14. Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research 22 (2012), 299–306.
15. Chassaing, B., Gewirtz, A.T., Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicologic Pathology 42 (2014), 49–53.
16. Chen, H.M., Yu, Y.N., Wang, J.L., Lin, Y.W., Kong, X., Yang, C.Q., et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. American Journal of Clinical Nutrition 97 (2013), 1044–1052.
17. Chung, H., Pamp, S.J., Hill, J.A., Surana, N.K., Edelman, S.M., Troy, E.B., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149 (2012), 1578–1593.
18. Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., The impact of the gut microbiota on human health: An integrative view. Cell 148 (2012), 1258–1270.
19. Costabile, A., Walton, G.E., Tzortzis, G., Vulevic, J., Charalampopoulos, D., Gibson, G.R., Development of a bread delivery vehicle for dietary prebiotics to enhance food functionality targeted at those with metabolic syndrome. Gut Microbes 6 (2015), 300–309.
20. D'Souza, S., Levy, E., Mack, D., Israel, D., Lambrette, P., Ghadirian, P., et al. Dietary patterns and risk for Crohn's disease in children. Inflammatory Bowel Diseases 14 (2008), 367–373.
21. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America 107 (2010), 14691–14696.
22. De Preter, V., Geboes, K., Verbrugghe, K., De Vuyst, L., Vanhoutte, T., Huys, G., et al. The in vivo use of the stable isotope-labelled biomarkers lactose-[N]ureide and [H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. British Journal of Nutrition 92 (2007), 439–446.
23. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., Kamada, N., Hickey, C.A., Wolter, M., et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 (2016), 1339–1353.
24. Eisenhofer, G., Aneman, A., Friberg, P., Hooper, D., Fandriks, L., Lonroth, L., et al. Substantial production of dopamine in the human gastrointestinal tract. Journal of Clinical Endocrinology & Metabolism 82 (1997), 3864–3871.
25. Fan, W., Huo, G., Li, X., Yang, L., Duan, C., Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life. Journal of Microbiology and Biotechnology 24 (2014), 133–143.
26. Fei, N., Zhao, L., An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. The ISME Journal 7 (2013), 880–884.
27. Fetissov, S.O., Hamze Sinno, M., Coeffier, M., Bole-Feysot, C., Ducrotte, P., Hokfelt, T., et al. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: Putative modulation by gut microflora. Nutrition 24 (2008), 348–359.
28. Gearry, R.B., Irving, P.M., Barrett, J.S., Nathan, D.M., Shepherd, S.J., Gibson, P.R., Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. Jouranl of Crohns Colitis 3 (2009), 8–14.
29. Geypens, B., Claus, D., Evenepoel, P., Hiele, M., Maes, B., Peeters, M., et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 41 (1997), 70–76.
30. Gibson, P.R., Use of the low-FODMAP diet in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 32 (2017), 40–42.
31. Gibson, P.R., Shepherd, S.J., Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology and Hepatology 25 (2010), 252–258.
32. Gold, J.S., Bayar, S., Salem, R.R., Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Archives of Surgery 139 (2004), 760–765.
33. Grander, C., Adolph, T.E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut, 2017, 10.1136/gutjnl-2016-313432.
34. Hallam, M.C., Barile, D., Meyrand, M., German, J.B., Reimer, R.A., Maternal high-protein or high-prebiotic-fiber diets affect maternal milk composition and gut microbiota in rat dams and their offspring. Obesity 22 (2014), 2344–2351.
35. Hammer, H.F., Hammer, J., Diarrhea caused by carbohydrate malabsorption. Gastroenterology Clinics of North America 41 (2012), 611–627.
36. Hildebrandt, M.A., Hoffmann, C., Sherrill-Mix, S.A., Keilbaugh, S.A., Hamady, M., Chen, Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (2009), 1716–1724.
37. Hold, G.L., Pryde, S.E., Russell, V.J., Furrie, E., Flint, H.J., Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiology Ecology 39 (2002), 33–39.
38. van Houtert, M.F.J., The production and metabolism of volatile fatty acids by ruminants fed roughages: A review. Animal Feed Science and Technology 43 (1993), 189–225.
39. Human Microbiome Project, C., Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
40. Hu, X., Wang, T., Jin, F., Alzheimer's disease and gut microbiota. Science China Life Sciences 59 (2016), 1006–1023.
41. Islam, K.B., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141 (2011), 1773–1781.
42. Jenkins, T.A., Nguyen, J.C., Polglaze, K.E., Bertrand, P.P., Influence of Tryptophan and Serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8 (2016), 56–70.
43. Kaliannan, K., Wang, B., Li, X.Y., Bhan, A.K., Kang, J.X., Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity. Int. J. Obes. 40 (2016), 1039–1042.
44. Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7 (2012), e47713–e47723.
45. Kurdi, P., Kawanishi, K., Mizutani, K., Yokota, A., Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. Journal of Bacteriology 188 (2006), 1979–1986.
46. Lattimer, J.M., Haub, M.D., Effects of dietary fiber and its components on metabolic health. Nutrients 2 (2010), 1266–1289.
47. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
48. Le Gall, G., Noor, S.O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I.T., et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. Journal of Proteome Research 10 (2011), 4208–4218.
49. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupon, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102 (2005), 11070–11075.
50. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
51. Li, M., Bauer, L.L., Chen, X., Wang, M., Kuhlenschmidt, T.B., Kuhlenschmidt, M.S., et al. Microbial composition and in vitro fermentation patterns of human milk oligosaccharides and prebiotics differ between formula-fed and sow-reared piglets. Journal of Nutrition 142 (2012), 681–689.
52. Lim, S.M., Kim, D.H., Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-kappaB activation and lipopolysaccharide production by gut microbiota. Nutrition Research 41 (2017), 86–96.
53. Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One 8 (2013), e53838–e53856.
54. Lui, J.B., Devarajan, P., Teplicki, S.A., Chen, Z., Cross-differentiation from the CD8 lineage to CD4 T cells in the gut-associated microenvironment with a nonessential role of microbiota. Cell Reports 10 (2015), 574–585.
55. Markle, J.G.M., Frank, D.N., Mortin-Toth, S., Robertson, C.E., Feazel, L.M., Rolle-Kampczyk, U., et al. Sex differences in the gut Microbiome drive hormone-dependent regulation of autoimmunity. Science 339 (2013), 1084–1088.
56. Marzocco, S., Dal Piaz, F., Di Micco, L., Torraca, S., Sirico, M.L., Tartaglia, D., et al. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease. Blood Purification 35 (2013), 196–201.
57. Mayer, E.A., Gut feelings: The emerging biology of gut-brain communication. Nature Reviews Neuroscience 12 (2011), 453–466.
58. McDermott, A.J., Huffnagle, G.B., The microbiome and regulation of mucosal immunity. Immunology 142 (2014), 24–31.
59. McIntosh, G.H., Royle, P.J., Playne, M.J., A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutrition and Cancer 35 (1999), 153–159.
60. Mozes, S., Bujnakova, D., Sefcikova, Z., Kmet, V., Developmental changes of gut microflora and enzyme activity in rat pups exposed to fat-rich diet. Obesity 16 (2008), 2610–2615.
61. Muegge, B.D., Kuczynski, J., Knights, D., Clemente, J.C., Gonzalez, A., Fontana, L., et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332 (2011), 970–974.
62. von Mutius, E., Environmental factors influencing the development and progression of pediatric asthma. The Journal of Allergy and Clinical Immunology 109 (2002), S525–S532.
63. Mutlu, E.A., Gillevet, P.M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P.A., et al. Colonic microbiome is altered in alcoholism. American Journal of Physiology - Gastrointestinal and Liver Physiology 302 (2012), G966–G978.
64. Neish, A.S., Microbes in gastrointestinal health and disease. Gastroenterology 136 (2009), 65–80.
65. O'Keefe, S.J., Diet, microorganisms and their metabolites, and colon cancer. Nature Reviews Gastroenterology & Hepatology 13 (2016), 691–706.
66. Ouwehand, A., Isolauri, E., Salminen, S., The role of the intestinal microflora for the development of the immune system in early childhood. European Journal of Nutrition 41:Suppl 1 (2002), I32–I37.
67. Parada, J., Santos, J.L., Interactions among starch, lipids, and proteins in foods: Microstructure control for glycemic response modulation. Critical Reviews in Food Science and Nutrition 56 (2016), 2362–2369.
68. Patterson, E., RM, O. D, Murphy, E.F., Wall, R., O, O. S, Nilaweera, K., et al. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. British Journal of Nutrition 111 (2014), 1905–1917.
69. Peek, R.M. Jr., Blaser, M.J., Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Reviews Cancer 2 (2002), 28–37.
70. Pluznick, J.L., Protzko, R.J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., et al. Olfactory receptor responding to gut microbiotaderived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America 110 (2013), 4410–4415.
71. Raybould, H.E., Gut chemosensing: Interactions between gut endocrine cells and visceral afferents. Autonomic Neuroscience 153 (2010), 41–46.
72. Rothe, M., Blaut, M., Evolution of the gut microbiota and the influence of diet. Beneficial Microbes 4 (2013), 31–37.
73. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 16767–16772.
74. Sarr, M.G., Billington, C.J., Brancatisano, R., Brancatisano, A., Toouli, J., Kow, L., et al. The EMPOWER study: Randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obesity Surgery 22 (2012), 1771–1782.
75. Schwarzer, M., Makki, K., Storelli, G., Machuca-Gayet, I., Srutkova, D., Hermanova, P., et al. Lactobacillus plantarum strain maintains growth of infant miceduring chronic undernutrition. Science 351 (2016), 854–857.
76. Shanahan, F., Probiotics and inflammatory bowel disease: Is there a scientific rationale?. Inflammatory Bowel Diseases 6 (2000), 107–115.
77. Shanahan, F., Probiotics in inflamatory bowel disease. Gut, 48, 2001, 609.
78. Shi, N., Li, N., Duan, X., Niu, H., Interaction between the gut microbiome and mucosal immune system. Mil. Med. Res. 4 (2017), 14–20.
79. Sipka, S., Bruckner, G., The immunomodulatory role of bile acids. International Archives of Allergy and Immunology 165 (2014), 1–8.
80. Smith, E.A., Macfarlane, G.T., Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microbial Ecology 33:3 (1997), 180–188.
81. Solomon, K.V., Haitjema, C.H., Henske, J.K., Gilmore, S.P., Borges-Rivera, D., Lipzen, A., et al. Early-branching gut fungi possess a large, comprehensive array of biomass-degrading enzymes. Science, 2016, 10.1126/science.aad1431.
82. Strachan, D.P., Hay fever, hygiene, and household size. BMJ 299 (1989), 1259–1260.
83. Tang, A.T., Choi, J.P., Kotzin, J.J., Yang, Y., Hong, C.C., Hobson, N., et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545 (2017), 305–310.
84. Tlaskalova-Hogenova, H., Stepankova, R., Hudcovic, T., Tuckova, L., Cukrowska, B., Lodinova-Zadnikova, R., et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 93 (2004), 97–108.
85. Trasande, L., Blustein, J., Liu, M., Corwin, E., Cox, L.M., Blaser, M.J., Infant antibiotic exposures and early-life body mass. International Journal of Obesity 37 (2012), 16–23.
86. Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
87. Tsavkelova, E.A., Klimova, S.Y., Cherdyntseva, T.A., Netrusov, A.I., Hormones and hormone-like substances of microorganisms: A review. Applied Biochemistry and Microbiology 42 (2006), 229–235.
88. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
89. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D., et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342 (2013), 971–976.
90. Walker, J.R., Ediger, J.P., Graff, L.A., Greenfeld, J.M., Clara, I., Lix, L., et al. The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. American Journal of Gastroenterology 103 (2008), 1989–1997.
91. Wang, X., Yang, Y., Moore, D.R., Nimmo, S.L., Lightfoot, S.A., Huycke, M.M., 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142 (2012), 543–551.
92. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
93. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
94. Wu, H., Esteve, E., Tremaroli, V., Khan, M.T., Caesar, R., Mannerås-Holm, L., et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nature Medicine, 2017, 10.1038/nm.4345.
95. Xu, J., Bjursell, M.K., Himrod, J., Deng, S., Carmichael, L.K., Chiang, H.C., et al. A genomic view of the human: bacteroides thetaiotaomicron symbiosis. Science 299 (2003), 2074–2076.
96. Yadav, H., Lee, J.H., Lloyd, J., Walter, P., Rane, S.G., Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biology Chemistry. 288 (2013), 25088–25097.
97. Yan, A.W., Fouts, D.E., Brandl, J., Starkel, P., Torralba, M., Schott, E., et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53 (2011), 96–105.
98. Yang, N.J., Chiu, I.M., Bacterial signaling to the nervous system through toxins and metabolites. Journal of Molecular Biology 429 (2017), 587–605.
99. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
100. Zhou, S.Y., Leelasinjaroen, P., Wu, X., Zhou, H., Lu, Y., Song, I., et al. 164 FODMAP diet modulates visceral nociception by changing gut microbiota and intestinal inflammation. Gastroenterology, 144, 2013, S-38.